成人黄色一区二区三区,97人人爱,午夜国产精品视频

Honz Profile

Honz Pharmaceutical Co., Ltd. (hereinafter referred to as Honz Pharma), is a publicly listed company centered on medicines for children. The company’s practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. As a Key New Technology Enterprise of the National Torch Program, HonzPharma was a pioneer in establishing the first enterprise post-doctoral research station primarily for children’s medicines.

At the beginning of 2020, The Covid-19 Epidemic situation swept the world. Honz Pharma produced medical face masks and other protective materials urgently, and built the first production line of Single-use medical face masks in Hainan Province in only 8 days. While Honz Pharma is actively building the medical protection production base, and perfecting the chain of epidemic prevention and disaster prevention, it is also vigorously promoting the CE certification of medical devices, so as to meet the domestic strategic reserve demand, as well as to turn crises into opportunities for cultivating new economic growth areas.

Honz Pharma follows the philosophy of “Honest, Responsible Medicine for the Good of Mankind”, implements the business strategy of “Making High Quality Medicines and Focusing on the Professional Market”, takes initiative to realize its “Strategy of Children’s Healthcare” and “Strategy of High Quality for Unmet Needs”, and devotes itself to becomingthe leading brand in the children’s healthcare industry in China. The company has grown rapidly in the pediatric medicines field, and has won “Top Ten Most Potential Chinese Pharmaceutical Companies”, “Forbes China Best SMEs”, “Top 500 Asia Brand” and other distinguished awards.

With years of in-depth experience in the children’s medication market, the company has formed an integrated structure of products, created a successful line of children’s medicines centered on “Honz” branded products, and launched unique Honz star products such as “Ruizhiqing”, “Kangzhisong”, “Kangzhitai”,and “Jinlishuang” ，owning one new product of National medicine category I. After years of dedication and development, Honz has become a household brand of medicines for children in China, and the “Honz” brand has also been rated as “China’s Well-Known Trademark”. In the future, Honz Pharma’s business operations will cover medicines for children, healthcare products, food, medical equipment, and other high-end health products and health services related to children.

Honz Pharma has five highly automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong, and is constructing a new manufacturing base meeting the EU GMP standards in Zhongshan, Guangdong. The company has brought in advanced quality control equipment and technologies from Switzerland, Germany, United States,Japan and other countries, besides its existing mass-scale, intelligent granule-preparation dispensing andpackaging production lines. The company emphasizes the R&D and innovation of products,has dedicated advanced equipment and exceptional R&D staff, and has invested hundreds of millions of RMB in this field.

Honz Pharma adheres to the business philosophy of ‘Manufacturer-Distributor Alliance with Win-Win Cooperation’, and has created the highly competitive ‘New Honz Model’. It is a product manager-dominated, academics-based and all-channel-targeted marketing model which was established by focusing on the strategy of high quality products, maintaining the agent system and commission system governed under the principles of win-win cooperation, and applying careful distributor selection and strict sales control. The company has approximately 1,000 pharmaceutical distribution agents, more than 40,000 sales terminals, a professional and experienced marketing team, and a marketing network which covers the whole country.

Honz Pharma is public-spirited. In the past years, we fulfilled our social responsibilities as a corporate citizen in the disaster relief of Indonesian tsunami, Ya’an earthquake and other disasters and educational grant programs for children in poor mountainous areas. In September 2011, Honz Pharma jointly founded the Honz Healthy Growth Foundation with the China Children and Teenagers Foundation.Through its Library Project, Children’s Well-Being Project, Home-Visit with Love Project, material donations and initiatives in other forms, the Honz Healthy Growth Foundation has benefitted more than ten million children across China.

In the future, Honz will carry on the cooperate legacy of ‘Sincere, Caring, Innovative’, and shoulder the responsibility of caring for and supporting children’s health and well-being. We are dedicated to serving as an expert that researches, develops and manufactures safe, effective and suitable high quality medicines as an expert that guides rational medication, as a pioneer that applies advanced science and technology in children’s health products and services, and as a promoter and guardian for children’s healthy development and growth.

About Honz

Professional Production

Innovative Research & Development

Product Center

Social Responsibility

Contact Us

About Honz

Professional Production

Innovative R&D

Products Center

Social Responsibility

Contact Us